LA demonstrates anti-inflammatory activity via interaction with MAPK, NF-κB, NLRP3, and Nrf2 signaling in the acute lung, kidney, and liver injury (acute inflammation) and arthritis and asthma (chronic inflammation) (Figure 4; Table 2). The gene discussed is NFKB1; the disease is arthritic joint disease.